Stock Markets
PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance
PETACH TIKVA, Israel, Nov. 29, 2024 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: NASDAQ:) (PolyPid or the Company), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it has received a written notification (the “Notification Letter”) from the Listing Qualifications staff of The Nasdaq Stock Market LLC (Nasdaq) notifying the Company that it is no longer in compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market, listing Rule 5550(b)(1), due to its failure to maintain a minimum of $2,500,000 in stockholders’ equity. In the Company’s Form 6-K dated November 13, 2024, the Company reported stockholders’ equity of approximately $2,158,000 as of September 30, 2024.
In accordance with Nasdaq rules, the Company has 45 calendar days, or until January 9, 2025, to submit a plan to regain compliance. If the plan is accepted, Nasdaq can grant an extension of up to 180 calendar days from the date of the letter to evidence compliance. The Notification Letter has no immediate effect on the Company’s listing on the Nasdaq Capital Market, and during the grace period, as may be extended, the Company’s ordinary shares will continue to trade on Nasdaq under the symbol PYPD.
Outcome of the unblinded interim analysis in Company’s ongoing SHIELD II Phase 3 trial evaluating D-PLEX ‚ ‚€ ‚€ for the prevention of abdominal colorectal surgical site infections is expected in December 2024. Under the terms of the Company’s private placement financing that closed in January 2024 (January PIPE), the Company has the potential to secure an additional $18.5 million if the unblinded interim analysis results in the stopping of the trial due to positive efficacy and all warrants are exercised. In addition, under the terms of the private placement financing that closed in August 2024 (August PIPE), the Company has the potential to secure an additional $6.1 million if the unblinded interim analysis results in either the stopping of the trial due to positive efficacy, or continuation to planned patient recruitment (up to 630 subjects) and all warrants are exercised. The Company expects that it will be able to demonstrate compliance with the Nasdaq stockholders’ equity requirement if warrants issued under the January PIPE and the August PIPE are exercised.
About PolyPid
PolyPid Ltd. (Nasdaq: PYPD) is a late-stage biopharma company aiming to improve surgical outcomes. Through locally administered, controlled, prolonged-release therapeutics, PolyPid’s proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with Active Pharmaceutical (TADAWUL:) Ingredients (APIs), enabling precise delivery of drugs at optimal release rates over durations ranging from several days to months. PolyPid’s lead product candidate D-PLEX ‚ ‚€ ‚€ is in Phase 3 clinical trial for the prevention of abdominal colorectal surgical site infections. In addition, the Company is currently in preclinical stages to test the efficacy of OncoPLEX for the treatment of solid tumors, beginning with glioblastoma.
For additional Company information, please visit http://www.polypid.com and follow us on Twitter and LinkedIn.
Forward-looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act and other securities laws. Words such as expects, anticipates, intends, plans, believes, seeks, estimates and similar expressions or variations of such words are intended to identify forward-looking statements. For example, the Company is using forward-looking statements when it discusses regaining compliance with Nasdaq’s continued listing requirements, the timing and effect thereof, and Company’s expectation that if warrants issued in the January PIPE and August PIPE are exercised, the Company will be able to demonstrate compliance with the Nasdaq stockholders’ equity requirement. Forward-looking statements are not historical facts, and are based upon management’s current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management’s expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company’s reports filed from time to time with the Securities and Exchange Commission, including, but not limited to, the risks detailed in the Company’s Annual Report on Form 20-F filed on March 6, 2024. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements.
References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. PolyPid is not responsible for the contents of third-party websites.
Contacts:
PolyPid Ltd.
Ori Warshavsky
COO “ US
908-858-5995
IR@Polypid.com
Investors:
Brian Ritchie
LifeSci Advisors
212-915-2578
BRitchie@lifesciadvisors.com
Stock Markets
US economy eyes strong finish ahead of heightened policy uncertainty in 2025
By Lucia Mutikani
WASHINGTON (Reuters) -The number of Americans filing new applications for jobless benefits fell more than expected last week, reversing the prior week’s jump and suggesting that a gradual labor market slowdown remained in place.
Other data on Thursday showed the economy grew faster than previously estimated in the third quarter, driven by robust consumer spending. The upbeat report came a day after the Federal Reserve delivered a third consecutive interest rate cut, but projected only two rate reductions in 2025, citing the economy’s continued resilience and still-elevated inflation.
Fed Chair Jerome Powell told reporters on Wednesday that the “downside risks of the labor market do appear to have diminished,” adding that “the U.S. economy has just been remarkable, I feel very good about where the economy is.”
“The economy is set to end 2024 on a solid note, which is fortunate since we’ll have to contend with heightened policy uncertainty and possibly greater challenges in 2025,” said Oren Klachkin, financial markets economist at Nationwide.
Initial claims for state unemployment benefits dropped 22,000 to a seasonally adjusted 220,000 for the week ended Dec. 14, the Labor Department said. Economists polled by Reuters had forecast 230,000 claims for the latest week. They had jumped 17,000 in the prior week. Claims have entered a period of volatility, which could see large swings in the data.
Unadjusted claims plunged 57,932 to 251,527 last week, pulled down by large decreases in New York, California, Georgia, Illinois, Michigan, Minnesota, Texas, Washington state, Wisconsin, New Jersey and Ohio.
A range of indicators, including job openings, suggests that conditions are much looser than they were before the COVID-19 pandemic, but the labor market is slowing in an orderly fashion.
A jump in the unemployment rate to 4.3% in July from 3.7% at the start of the year saw the U.S. central bank kicking off its policy easing cycle with an unusually large half-percentage-point interest rate cut in September. The Fed on Wednesday cut its benchmark overnight interest rate by 25 basis points to the 4.25%-4.50% range.
In September, the Fed had penciled in four quarter-point rate cuts in 2025. The shallower rate cut path for next year in the latest projections also reflected uncertainty over policies from President-elect Donald Trump’s incoming administration, including tariffs on imported goods, tax cuts and mass deportations of undocumented immigrants, which economists have warned would be inflationary.
The Fed hiked its policy rate by 5.25 percentage points between March 2022 and July 2023 to tame inflation.
The dollar was steady against a basket of currencies. U.S. Treasury yields rose.
ROBUST CONSUMER SPENDING
The claims data covered the week during which the government surveyed businesses for the nonfarm payrolls component of December’s employment report. Claims rose marginally between the November and December survey periods.
Nonfarm payrolls increased by 227,000 jobs in November, in part boosted by the fading drag from hurricanes and the end of strikes by factory workers at Boeing (NYSE:) and another small aerospace company. These factors had restricted job growth to only 36,000 in October.
Data next week on the number of people on unemployment rolls will shed more light on the labor market’s health in December.
The number of people receiving benefits after an initial week of aid, a proxy for hiring, slipped 5,000 to a seasonally adjusted 1.874 million during the week ending Dec. 7, the claims report showed.
The labor market resilience, mostly reflecting historic low layoffs, has been driving the economic expansion through strong consumer spending.
A separate report from the Commerce Department showed stronger economic growth than previously estimated in the third quarter. Gross domestic product increased at an upwardly revised 3.1% annualized rate, the Commerce Department’s Bureau of Economic Analysis said in its third estimate of third-quarter GDP. The economy was previously reported to have expanded at a 2.8% pace last quarter.
Economists forecast GDP would be unrevised. The revision reflected upgrades to consumer spending and export growth, which offset a downward revision to private inventory investment and upward revision to imports.
The economy grew at a 3.0% pace in the April-June quarter. It is expanding at a pace that is well above what Fed officials regard as the non-inflationary growth rate of around 1.8%.
Consumer spending, which accounts for more than two-thirds of economic activity, grew at a 3.7% pace. That was revised up from the previously estimated 3.5% rate.
A measure of domestic demand that excludes government spending, trade and inventories increased at a 3.4% pace. Final sales to private domestic purchasers were previously estimated to have risen at a 3.2% rate. Domestic demand increased at a 2.7% pace in the second quarter.
National after-tax profits without inventory valuation and capital consumption adjustments decreased $15.0 billion, or 0.4%. They were previously estimated to have risen $0.2 billion, or unchanged in percentage terms.
When measured from the income side, the economy grew at a 2.1% rate last quarter, lowered from the initially estimated 2.2% pace. Gross domestic income (GDI) increased at a 2.0% rate in the second quarter.
In principle, GDP and GDI should be equal, but in practice they differ as they are estimated using different and largely independent source data. Annual benchmark revisions have sharply narrowed the gap between GDP and GDI.
The average of GDP and GDI, also referred to as gross domestic output and considered a better measure of economic activity, increased at a 2.6% rate. That was revised up from the 2.5% rate reported last month. Gross domestic output grew at a 2.5% pace in the April-June quarter.
Stock Markets
Suspect in killing of UnitedHealth executive faces federal murder charge
By Julio-Cesar Chavez, Jonathan Allen and Luc Cohen
NEW YORK (Reuters) -The suspect in the killing of UnitedHealth Group (NYSE:) executive Brian Thompson is being charged with federal murder and stalking crimes, according to a court document filed on Thursday, alongside state murder and terrorism charges previously announced by New York prosecutors.
Federal prosecutors in Manhattan are charging Luigi Mangione, 26, with the federal crime of murder using a firearm, two charges of stalking and an additional firearms offense, according to a criminal complaint. Prosecutors say that Mangione “traveled in interstate commerce” by taking a bus from Atlanta to New York before Thompson’s killing, and so have jurisdiction.
Mangione was transferred into the custody of New York City police earlier on Thursday after he waived his right to extradition proceedings at a court hearing in Pennsylvania, the state where he was arrested following a five-day manhunt.
According to the complaint, a notebook Altoona police found in Mangione’s possession contained several handwritten pages that “express hostility towards the health insurance industry and wealthy executives in particular.” A notebook entry dated Oct. 22 described an intent to “wack” the chief executive of an insurance company at its investor conference.
A grand jury in New York has indicted Mangione on 11 counts, including first-degree murder and murder as an act of terrorism. Mangione has been in jail since his arrest and has not yet entered a plea. His New York defense lawyer, Karen Friedman Agnifilo, has said Mangione has been “overcharged” and that he would fight the charges in court.
Mangione was arrested in Altoona, Pennsylvania, on Dec. 9, five days after Thompson was fatally shot outside a Manhattan hotel before a company conference in what law-enforcement officials have called a premeditated assassination.
While the killing of Thompson has been broadly condemned, Mangione has been feted as a folk hero by some Americans who decry the steep costs of healthcare and the power that insurance companies have to deny paying for some medical treatments. A small crowd of supporters stood outside the courthouse, some waving signs that condemned the health insurance industry.
Federal charges potentially allow prosecutors to pursue the death penalty, which has been outlawed in New York for decades.
Mangione is due to make an initial court appearance on the federal charges before U.S. Magistrate Judge Katharine Parker in Manhattan on Thursday afternoon.
“The federal government’s reported decision to pile on top of an already overcharged first-degree murder and state terror case is highly unusual and raises serious constitutional and statutory double jeopardy concerns,” Mangione’s lawyer Friedman Agnifilo said in a statement. “We are ready to fight these charges in whatever court they are brought.”
In Pennsylvania, police said Mangione had a self-assembled 9mm handgun in his backpack and a homemade silencer when he was arrested after being spotted at a McDonald’s (NYSE:) restaurant. The handgun resembled the weapon used to kill Thompson, CEO of UnitedHealthcare, the largest U.S. health insurer.
Mangione, a Maryland native who had lived in Hawaii, also had multiple fake identification documents, including a fake New Jersey ID that was used to check into a Manhattan hostel days before Thompson’s shooting, police said.
In Pennsylvania, Mangione has been charged with forgery and illegally possessing an unlicensed gun.
At the Blair County courthouse on Thursday morning, Mangione, appearing in an orange jail jumpsuit, had a preliminary hearing for the Pennsylvania charges, immediately followed by a second on New York’s extradition request. The Pennsylvania prosecutors told the court they had agreed to pause the Pennsylvania proceedings until after the conclusion of the New York prosecution.
Mangione spoke only briefly at the extradition hearing, saying he understood his rights and telling Judge David Consiglio he consented to surrender to New York police.
Manhattan District Attorney Alvin Bragg’s office is accusing Mangione of an act of terrorism under New York law because Thompson’s killing was intended to intimidate or coerce civilians or “influence the policies of a unit of government.”
Stock Markets
Acurast Unveils Processor Lite for iOS: Empowering iPhone Users to Join the DePIN Cloud Rebellion Secured by Polkadot
Zug, Switzerland, December 19th, 2024, Chainwire
Acurast, a leader in decentralized confidential cloud computing, announces the launch of Acurast Processor Lite for iOS, now available on the Apple (NASDAQ:) App Store. This application allows iPhone users to share their device’s computing power with Acurast’s decentralized confidential cloud network, offering an opportunity to earn rewards in return.
By harnessing the advanced processors in mobile devices, Acurast makes it possible for regular phones to operate as powerful computing providers. With this new expansion to iOS, Acurast’s ecosystem grows bigger, welcoming iPhone users into a network that’s changing the way cloud computing is done. This shift marks a step forward in accessibility and control over how compute power is managed worldwide.
Acurast also takes a unique, sustainable approach: repurposing mobile phones with damaged screens or unused older models into affordable compute resources. These upcycled devices become cost-effective alternatives to traditional servers, bringing sustainability into the heart of cloud infrastructure.
Users providing compute power through Acurast Processor Lite can earn rewards in the form of cACU tokens. Each user can earn up to 250 cACU per month in bootstrapping rewards simply by running the Processor connected to the internet. Additional rewards are earned whenever developers deploy applications on the Acurast Cloud and utilize the user’s Processor resources.
Key Features of Acurast Processor Lite for iOS:
● Providing Compute Power Used By Developers To Deploy Their Applications: Getting started with users’ everyday phones or onboard upcycled devices.
● Broading Compatibility: Supports iPhone 6s and newer models, allowing a wide range of users to participate.
● Secure and Private: Maintains data security and user privacy, giving users peace of mind.
iPhone users can join the Acurast Cloud Rebellion by downloading Processor Lite iOS. Whether with an everyday phone or dedicated upcycled devices, joining means earning rewards and supporting a shift toward a more decentralized, sustainable, and user-driven confidential cloud infrastructure.
Alessandro De Carli, Co-Founder of Acurast shared, “With the launch of Acurast Processor Lite for iOS, we’re taking a significant step toward democratizing cloud computing. By enabling iPhone users to contribute their phones’ compute power, we’re building a more decentralized, secure, and confidential cloud infrastructure. This is not just about technology; it’s about empowering individuals to be part of a global movement that redefines how we think about and utilize computing resources.”
Users can download Processor iOS Lite here: Processor iOS Lite
About Acurast
Acurast is transforming the cloud landscape by championing mobile-powered disruption in decentralized, confidential, and accessible computing. By enabling individuals to contribute compute power from their phones, Acurast is building a decentralized, serverless cloud that democratizes access to computing resources.
Press Contact:
Pascal Brun
Co-Founder
Acurast Association
Email: pascal@acurast.com
ContactComms and PR managerJonathan DuranDistractiveJonathan@distractive.xyz
- Forex2 years ago
Forex Today: the dollar is gaining strength amid gloomy sentiment at the start of the Fed’s week
- Forex2 years ago
How is the Australian dollar doing today?
- Forex2 years ago
Unbiased review of Pocket Option broker
- Forex2 years ago
Dollar to pound sterling exchange rate today: Pound plummeted to its lowest since 1985
- Cryptocurrency2 years ago
What happened in the crypto market – current events today
- World2 years ago
Why are modern video games an art form?
- Commodities2 years ago
Copper continues to fall in price on expectations of lower demand in China
- Forex2 years ago
The dollar is down again against major world currencies